← Open Payments lookup

ASHLEY GLEASON: Open Payments

NPI 1316637846 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,676 in 93 payments from 11 companies in 2025. Trend: 2023 $606 · 2024 $873 · 2025 $1,676

Food & beverage: $1,676
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)43$609
Vanda Pharmaceuticals Inc.13$277
Otsuka America Pharmaceutical, Inc.15$208
Janssen Pharmaceuticals, Inc6$202
ABBVIE INC.3$88
Axsome Therapeutics, Inc.3$70
Alkermes, Inc.3$70
E.R. Squibb & Sons, L.L.C.2$50
Neurocrine BioSciences, Inc.2$43
Takeda Pharmaceuticals U.S.A., Inc.2$30

Products named: CAPLYTA, FANAPT, INVEGA SUSTENNA, REXULTI, ABILIFY MAINTENA, VRAYLAR, Auvelity, ARISTADA.

Industry payments across CA — which companies pay providers there.